Status:

COMPLETED

Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU)

Lead Sponsor:

Boston Scientific Corporation

Conditions:

Venous Leg Ulcer

Eligibility:

All Genders

18+ years

Brief Summary

A 12 month, multicenter, open-label registry to observe chronic venous insufficiency resulting in VLU treated with Varithena.

Detailed Description

This 12 month, multicenter, open-label registry is designed to collect treatment and outcome data related to participants treated with Varithena for great saphenous vein (GSV) system and/or anterior a...

Eligibility Criteria

Inclusion

  • Men and women; age ≥18
  • Investigator has selected Varithena® to treat participants classified C6 with chronic (≥3 months) VLU resulting from GSV and/or AASV incompetence
  • Wound can be visualized in one plane to allow for image collection of the entire wound in one photograph, or if wound is circumferential, participant must be able to capture the entire wound using multiple photographs taken from directly above the wound (straight on)
  • Reflux \>500 milliseconds (ms) on duplex ultrasound
  • Willing and able to collect wound photographs and data using an application installed on a tablet
  • Willing and able to return for scheduled follow-up and wound care visits
  • Ability to comprehend and sign informed consent form (ICF) and complete questionnaires

Exclusion

  • Contraindications to Varithena® 1% in accordance with the FPI
  • Any serious concomitant disease, per physician's discretion, that confounds wound healing, including malignant changes of wound
  • Concomitant heat ablation, or heat ablation of index leg within 6 weeks prior to treatment with Varithena®
  • Significant arterial disease or ankle-brachial pressure index (ABPI) ≤0.8
  • In the opinion of Investigator, wound would close within 12 weeks without additional treatment

Key Trial Info

Start Date :

September 29 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 28 2020

Estimated Enrollment :

76 Patients enrolled

Trial Details

Trial ID

NCT03257254

Start Date

September 29 2017

End Date

September 28 2020

Last Update

December 14 2021

Active Locations (14)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (14 locations)

1

Stanford University

Palo Alto, California, United States, 94304

2

University of California Davis Health

Sacramento, California, United States, 95817

3

The Vascular Experts

Darien, Connecticut, United States, 06820

4

Pines Clinical Research

Aventura, Florida, United States, 33180